ILLUMINA, INC. Net Income (Loss), Including Portion Attributable to Nonredeemable Noncontrolling Interest
ILLUMINA, INC. (ILMN) reported Net Income (Loss), Including Portion Attributable to Nonredeemable Noncontrolling Interest of -$4.40 billion for the 12-month period ending 2023-01-01, per its 10-K filed 2023-02-17.
Discontinued › Shareholders' Equity
us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest · last filed 2023-02-17
- ILLUMINA, INC. net income (loss), including portion attributable to nonredeemable noncontrolling interest for the quarter ending 2020-09-27 was $179.00M, a 23.50% decline year-over-year.
- ILLUMINA, INC. net income (loss), including portion attributable to nonredeemable noncontrolling interest for the quarter ending 2020-06-28 was $47.00M, a 84.07% decline year-over-year.
- ILLUMINA, INC. net income (loss), including portion attributable to nonredeemable noncontrolling interest for the quarter ending 2020-03-29 was $173.00M, a 25.11% decline year-over-year.
- ILLUMINA, INC. net income (loss), including portion attributable to nonredeemable noncontrolling interest for the quarter ending 2019-12-29 was $239.00M, a 16.02% increase year-over-year.
- ILLUMINA, INC. net income (loss), including portion attributable to nonredeemable noncontrolling interest for fiscal 2023 was -$4.40B, a 677.95% decline from fiscal 2022.
- ILLUMINA, INC. net income (loss), including portion attributable to nonredeemable noncontrolling interest for fiscal 2022 was $762.00M, a 16.16% increase from fiscal 2021.
- ILLUMINA, INC. net income (loss), including portion attributable to nonredeemable noncontrolling interest for fiscal 2021 was $656.00M, a 34.33% decline from fiscal 2019.
- ILLUMINA, INC. net income (loss), including portion attributable to nonredeemable noncontrolling interest for fiscal 2019 was $999.00M, a 22.43% increase from fiscal 2018.
| Period end | Net Income (Loss), Including Portion Attributable to Nonredeemable Noncontrolling Interest 3 month | Net Income (Loss), Including Portion Attributable to Nonredeemable Noncontrolling Interest 6 month | Net Income (Loss), Including Portion Attributable to Nonredeemable Noncontrolling Interest 9 month | Net Income (Loss), Including Portion Attributable to Nonredeemable Noncontrolling Interest 12 month | Net Income (Loss), Including Portion Attributable to Nonredeemable Noncontrolling Interest 12 month as first filed |
|---|---|---|---|---|---|
| 2023-01-01 | -$4.40B 10-K · filed 2023-02-17 | ||||
| 2022-01-02 | $762.00M 10-K · filed 2023-02-17 | ||||
| 2021-01-03 | $656.00M 10-K · filed 2023-02-17 | ||||
| 2020-09-27 | $179.00M 10-Q · filed 2020-10-30 | $226.00M derived: sum of 2 quarters · filed 2020-10-30 | $399.00M derived: sum of 3 quarters · filed 2020-10-30 | $638.00M derived: sum of 4 quarters · filed 2020-10-30 | |
| 2020-06-28 | $47.00M 10-Q · filed 2020-10-30 | $220.00M derived: sum of 2 quarters · filed 2020-10-30 | $459.00M derived: sum of 3 quarters · filed 2020-10-30 | $693.00M derived: sum of 4 quarters · filed 2020-10-30 | |
| 2020-03-29 | $173.00M 10-Q · filed 2020-10-30 | $412.00M derived: sum of 2 quarters · filed 2020-10-30 | $646.00M derived: sum of 3 quarters · filed 2020-10-30 | $941.00M derived: sum of 4 quarters · filed 2020-10-30 | |
| 2019-12-29 | $239.00M 10-Q · filed 2020-10-30 | $473.00M derived: sum of 2 quarters · filed 2020-10-30 | $768.00M derived: sum of 3 quarters · filed 2020-10-30 | $999.00M 10-K · filed 2022-02-18 | |
| 2019-09-29 | $234.00M 10-Q · filed 2020-10-30 | $529.00M derived: sum of 2 quarters · filed 2020-10-30 | $760.00M derived: sum of 3 quarters · filed 2020-10-30 | $966.00M derived: sum of 4 quarters · filed 2020-10-30 | |
| 2019-06-30 | $295.00M 10-Q · filed 2020-10-30 | $526.00M derived: sum of 2 quarters · filed 2020-10-30 | $732.00M derived: sum of 3 quarters · filed 2020-10-30 | $928.00M derived: sum of 4 quarters · filed 2020-10-30 | |
| 2019-03-31 | $231.00M 10-Q · filed 2020-10-30 | $437.00M derived: sum of 2 quarters · filed 2020-10-30 | $633.00M derived: sum of 3 quarters · filed 2020-10-30 | $840.00M derived: sum of 4 quarters · filed 2020-10-30 | |
| 2018-12-30 | $206.00M 10-Q · filed 2019-10-25 | $402.00M derived: sum of 2 quarters · filed 2019-10-25 | $609.00M derived: sum of 3 quarters · filed 2019-10-25 | $816.00M 10-K · filed 2021-02-17 | |
| 2018-09-30 | $196.00M 10-Q · filed 2019-10-25 | $403.00M derived: sum of 2 quarters · filed 2019-10-25 | $610.00M 10-Q · filed 2018-10-24 | $678.00M derived: sum of 4 quarters · filed 2020-02-11 | |
| 2018-07-01 | $207.00M 10-Q · filed 2019-10-25 | $414.00M 10-Q · filed 2018-07-31 | $482.00M derived: sum of 3 quarters · filed 2020-02-11 | $645.00M derived: sum of 4 quarters · filed 2020-02-11 | |
| 2018-04-01 | $207.00M 10-Q · filed 2019-10-25 | $275.00M derived: sum of 2 quarters · filed 2020-02-11 | $438.00M derived: sum of 3 quarters · filed 2020-02-11 | $566.00M derived: sum of 4 quarters · filed 2020-02-11 | |
| 2017-12-31 | $68.00M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-11 | $231.00M derived: sum of 2 quarters · filed 2020-02-11 | $359.00M derived: sum of 3 quarters · filed 2020-02-11 | $719.00M 10-K · filed 2020-02-11 | |
| 2017-10-01 | $163.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-25 | $291.00M derived: sum of 2 quarters · filed 2017-10-25 | $651.00M 10-Q · filed 2017-10-25 | $767.66M derived: sum of 4 quarters · filed 2019-02-12 | |
| 2017-07-02 | $128.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-03 | $488.00M 10-Q · filed 2017-08-03 | $604.66M derived: sum of 3 quarters · filed 2019-02-12 | $728.12M derived: sum of 4 quarters · filed 2019-02-12 | |
| 2017-04-02 | $360.00M 10-Q · filed 2017-05-05 | $476.66M derived: sum of 2 quarters · filed 2019-02-12 | $600.12M derived: sum of 3 quarters · filed 2019-02-12 | $719.79M derived: sum of 4 quarters · filed 2019-02-12 | |
| 2017-01-01 | $116.66M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-12 | $240.12M derived: sum of 2 quarters · filed 2019-02-12 | $359.80M derived: sum of 3 quarters · filed 2019-02-12 | $449.00M 10-K · filed 2019-02-12 | $448.83M 10-K · filed 2017-02-14 |
| 2016-10-02 | $123.46M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-08 | $243.13M derived: sum of 2 quarters · filed 2016-11-08 | $332.34M 10-Q · filed 2016-11-08 | ||
| 2016-07-03 | $119.68M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-02 | $208.88M 10-Q · filed 2016-08-02 | |||
| 2016-04-03 | $89.20M 10-Q · filed 2016-05-09 | ||||
| 2016-01-03 | $462.00M 10-K · filed 2018-02-13 | $461.56M 10-K · filed 2017-02-14 | |||
| 2014-12-28 | $353.35M 10-K · filed 2017-02-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| WATERS CORP /DE/ (WAT) | United States | $42.297B | 224.28 |
| AGILENT TECHNOLOGIES, INC. (A) | United States | $48.720B | 27.14 |
| METTLER TOLEDO INTERNATIONAL INC/ (MTD) | $30.436B | 30.62 | |
| REVVITY, INC. (RVTY) | United States | $16.814B | 53.44 |
| Avantor, Inc. (AVTR) | United States | $10.501B | -9.72 |
| BRUKER CORP (BRKR) | United States | $9.706B | -128.75 |
| Alamar Biosciences, Inc. (ALMR) | United States | $2.300B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |